Atlas Trials

Artificial Intelligence-assisted HER2 Expression Assessment in Urothelial Carcinoma Based on Imaging-pathology Omics

Clinical trial NCT07454941 · ENROLLING_BY_INVITATION

Trial details

NCT number
NCT07454941
Sponsor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Status
ENROLLING_BY_INVITATION
Study type
OBSERVATIONAL
Urothelial Carcinoma (UC)HER2Diagnostic
Start date
2026-03-02
Primary completion
2028-06-03
Enrollment
4000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.